• Policy
• ICER of general drugs KRW 15.97 mil for the past 15 yrs
• by Lee, Tak-Sun Dec 19, 2022 04:35am

• Policy
• Pfizer Cibinqo, re-applied to the HIRA
• by Lee, Tak-Sun Dec 19, 2022 04:35am

• Policy
• Green light for the reimb of Onureg, Rolontis, etc.
• by Lee, Tak-Sun Dec 19, 2022 04:35am

• Policy
• HIRA, established a management system for high-priced drugs
• by Lee, Tak-Sun Dec 19, 2022 04:34am

• Policy
• Discard Moon Care Policy
• by Lee, Jeong-Hwan Dec 19, 2022 04:34am

• Policy
• MFDS approves Jemperil, the third PD-1 inhibitor in Korea
• by Lee, Hye-Kyung Dec 15, 2022 05:55am

• Policy
• MFDS “Increasing AAP manufacturing well in progress”
• by Lee, Hye-Kyung Dec 14, 2022 05:57am

• Policy
• $25.5 billion in exports to the health industry
• by Kim, Jung-Ju Dec 14, 2022 05:56am

• Policy
• Reimb of Samil·Kukje's rebamipide eye drops adequate
• by Lee, Tak-Sun Dec 13, 2022 06:07am

• Policy
• Big Pharma's sale of Old Drug has increased
• by Lee, Tak-Sun Dec 13, 2022 06:07am